17,731 options granted to Kodiak (NASDAQ: KOD) board director
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Kodiak Sciences Inc. director Bassil I. Dahiyat received a grant of stock options covering 17,731 shares of common stock. The options have an exercise price of $38.96 per share and expire on June 29, 2036.
All 17,731 option shares vest in a single tranche on the earlier of June 30, 2027 or one day before Kodiak’s next annual shareholder meeting after the grant date, provided Dahiyat continues to serve on the board through that vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Dahiyat Bassil I
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,731 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 17,731 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 17,731 shares
Exercise price: $38.96 per share
Expiration date: June 29, 2036
+2 more
5 metrics
Options granted
17,731 shares
Stock Option (Right to Buy) granted to director
Exercise price
$38.96 per share
Exercise price of granted stock options
Expiration date
June 29, 2036
Option term end date
Post-transaction derivative holdings
17,731 options
Total derivative securities following transaction
Vesting date reference
June 30, 2027
Cliff vesting date if earlier than next annual meeting
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 38.9600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the option shall vest upon the earlier of June 30, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-29T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did Kodiak Sciences (KOD) director Bassil Dahiyat receive in this Form 4?
Kodiak Sciences director Bassil Dahiyat received a grant of stock options for 17,731 shares of common stock at a $38.96 exercise price. These options are part of his director compensation and provide the right to buy shares in the future if conditions are met.
What is the vesting schedule of the 17,731 Kodiak Sciences (KOD) stock options?
All 17,731 options vest at once on the earlier of June 30, 2027 or one day before Kodiak’s next annual meeting after the grant date. Vesting requires Dahiyat to continue serving on the board through that applicable date.
What is the exercise price and expiration date of Bassil Dahiyat’s Kodiak Sciences (KOD) options?
The granted options have a $38.96 per share exercise price and expire on June 29, 2036. After expiration, any unexercised options become worthless, so exercise must occur before that date if vesting conditions are satisfied.
How many Kodiak Sciences (KOD) derivative securities does Bassil Dahiyat hold after this grant?
After the grant, Dahiyat holds stock options covering 17,731 shares of Kodiak Sciences common stock. These options currently represent his reported derivative holdings from this transaction and will only have value if the stock trades above the $38.96 exercise price after vesting.